Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
US8987249B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8987249-B2 |
| Application number | US-201414205861-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 12, 2014 |
| Priority date | Mar 14, 2013 |
| Publication date | Mar 24, 2015 |
| Grant date | Mar 24, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention relates to 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides of formula 1 and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases.
Opening claim text (preview).
We claim: 1. A compound of formula 1 wherein R 1 is independently selected from H, C 1-6 -alkyl-, halogen, HO—, C 1-6 -alkyl-O—, H 2 N—, C 1-6 -alkyl-HN—, (C 1-6 -alkyl) 2 N— and C 1-6 -alkyl-C(O)HN—; or two R 1 are together C 1-4 -alkylene; R 2 is selected from…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.